Merck Pays More Than $400 Million to Settle Federal, State Medicaid Fraud Investigation Sparked by Qui Tam Whistleblower Case Detailing Marketing Schemes for Vioxx(R), Zocor(R), Several O... (in a nationwide investigation by federal...)

HOME >> MEDICINE >> NEWS

Merck Pays More Than $400 Million to Settle Federal, State Medicaid Fraud Investigation Sparked by Qui Tam Whistleblower Case Detailing Marketing Schemes for Vioxx(R), Zocor(R), Several Other Drugs

Date:2/7/2008

in a nationwide investigation by federal and state prosecutors that returned hundreds of millions of taxpayer dollars to the Medicaid program," Cohen said.

"When we realized the extent of the fraud, we took the evidence straight to the Government. Taking on Merck required close coordination and cooperation between us and the state and federal prosecutors. This taskforce approach and unrelenting commitment won a huge victory for the taxpayers." Kleiman said.

"This landmark case exposed abuses of Medicaid's Best Price nominal price exception, and strengthened the Medicaid Rebate program to reduce the states' drug costs," Yeager said.

Aside from the huge settlement, the second largest FCA civil fraud Medicaid recovery, the case marked new ground with a collaborative investigation model that saw the relator and his lawyers work closely with state and federal Government investigators to press the case. This new investigative model, Cohen said, "will become the basis for future qui tam whistleblower investigations, especially in an age of shrinking government budgets."

The FCA, initially sponsored by President Abraham Lincoln to stop military fraud during the Civil War, allows private citizens with knowledge of fraud to help the Government recover ill-gotten gains and additional civil penalties. The FCA allows the Government to collect up to three times the amount it was defrauded, in addition to civil penalties of $5,500 to $11,000 per false claim. Whistleblowers whose cases settle or are won in court usually receive rewards representing 15 to 25 percent of qui tam recoveries.

The federal investigation was conducted by the U.S. Attorney's Office for the Eastern District of Pennsylvania, under the direction of Patrick L. Meehan, U.S. Attorney, Assistant U.S. Attorney Virginia Gibson, Chief of the Civil Division, and Assistant U.S. Attorney Viveca Parker. Parker led the broad investigation, including the review of more than 400 boxes of
'/>"/>

SOURCE PRforLAW, LLC
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3
Related medicine news :

1. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
2. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
3. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
4. ICx Technologies Works With Merck & Co., Inc. to Develop Cancer Diagnostic Technology
5. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
6. The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
7. Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
8. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
9. AHF Challenges Merck Over Steep Price of Its New AIDS Drug, Isentress
10. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
11. Merck & Co., Inc. Response to Todays New York Medicaid Suit

Post Your Comments:

(Date:12/14/2009)... ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ ... study (MTF) -- the largest survey on teen drug ... -- underscores that teens, intentional abuse of prescription (Rx) ... for concern, with an alarming number of young people ... ,, Teen Abuse of Medication Continues to ...

(Date:12/14/2009)... 14 The Hemophilia Federation of America ... issues involving the Teamsters Local 929 and the ... national blood system depends on skilled workers to ... is distilled into products such as clotting factor ... disease. ,, The Division of Blood Services ...

(Date:12/14/2009)... Exercise benefited men whose disease had been treated, hadn,t ... -- Exercise appears to reduce the risk of death ... study, which began in January 1986, included 668 men ... stage III colon cancer that had not spread (nonmetastatic ... that asked them about any new cancer and disease ...

(Date:12/14/2009)... protection, study finds, , , MONDAY, Dec. 14 (HealthDay News) ... their morning without a cup or two of java: ... developing type 2 diabetes. , That,s the conclusion ... coffee you drink, the lower your risk of diabetes. ... percent reduction in the risk of diabetes, the researchers ...

(Date:12/14/2009)... are underdiagnosed, poorly treated and highly stigmatized, according ... H. Rubin, M.D., Ph.D. So these Washington University ... problems. , In "Demystifying Psychiatry," Zorumski and Rubin, ... treating psychiatric patients and helping patient families, say ... and treatment result from a lack of understanding ...

Breaking Medicine News(10 mins):Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2 Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3 Health News:HFA Voices Blood Safety Concerns 2 Health News:Physical Activity May Prolong Survival After Colon Cancer 2 Health News:Coffee, Tea Might Stave Off Diabetes 2 Health News:Coffee, Tea Might Stave Off Diabetes 3 Health News:Book demystifies psychiatry for the general public 2 Health News:Book demystifies psychiatry for the general public 3

[0] Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results [0] HFA Voices Blood Safety Concerns [0] Physical Activity May Prolong Survival After Colon Cancer [0] Coffee, Tea Might Stave Off Diabetes [0] Book demystifies psychiatry for the general public

... Environmentalists want bisphenol A banned from products for infants ... organizations in the United States and Canada are calling ... bisphenol A (BPA) in baby bottles, toddler sippy cups, ... "This is quite concerning. All 19 polycarbonate bottles [investigated ...

... be getting an,unfair rap for disrupting women,s sleep at ... increase during the,transition into menopause, reinforcing the idea that ... in sleep laboratories, the,connection between hot flashes and sleep ... Women,s Health Watch., A new study concludes that ...

... -- A new study by researchers at Northwestern University,s ... how best to treat patients in respiratory distress in ... believed that high levels of carbon dioxide (CO2) or ... acute lung disease may be beneficial to them. Now, ...

... LAS VEGAS, Feb. 7 American Pacific,Corporation (Nasdaq: ... quarter ended December 31, 2007., We provide non-GAAP ... A reconciliation of the non-GAAP measures to the most ... data., FINANCIAL HIGHLIGHTS, Quarter Ended December 31, ...

... episode, OAKLAND, Calif., Feb. 7 Nytera Tilmon ... care for her seven children,all of whom live with ... a new television show revealing Nytera,s story and others,behind ... is,called "Union Time" and it,s the only national labor-produced ...

... After just seven months in print, Cell Stem Cell, ... New Journal - Science, Technology & Medicine, by the Professional ... Publishers (AAP). , This honor, which is among the Association ... a year after Cell Stem Cell published its first issue ...

Report Shows Dangerous Chemical Can Leach From Baby Bottles Hot Flashes Not Always to Blame for Sleep Problems in Menopausal Women, Reports the Harvard Women's Health Watch Study suggests new therapy for lung disease patients American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter Healthcare Crisis Brought to Life in New TV Show Cell Stem Cell named 'Best New Journal' of 2007

(Date:12/14/2009)... CHICAGO, Dec. 14 Sword Diagnostics, Inc. ... Patent Office (USPTO) has issued patent number ... Biological Organisms using Raman Scattering" to the company. ... on improved sensitivity. ,, "The issuance of ... move forward with our continued development and commercialization," ...

(Date:12/14/2009)... Dec. 14 Cardium Therapeutics (NYSE Amex: ... 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment ... Healing: Science and Industry Conference held December 10-13, ... The conference is attended by top industry leaders ... wound healing. Dr. Barbara K. Sosnowski, Cardium,s ...

(Date:12/14/2009)... Dec. 14 Authentidate Holding Corp. ... of secure Health Information Exchange and workflow ... of the Carolinas ("HCC"), a home health ... durable medical equipment supplier, have selected Authentidate,s ... standardize processes for the completion of patient ...

Breaking Medicine Technology:Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2 Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3 Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4 Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2 Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3 Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4 Heart Attacks Less Often Fatal Today 49550 1 Heart Attacks Less Often Fatal Today 49550 2 Heart Attacks Less Often Fatal Today 49550 3 EUROPACE raises remote monitoring profile 49546 1 EUROPACE raises remote monitoring profile 49546 2 EUROPACE raises remote monitoring profile 49546 3 Governor Rendell Discusses Impact of Budget on Services for Families of Children With Autism 49543 1 Governor Rendell Discusses Impact of Budget on Services for Families of Children With Autism 49543 2

[0] U.S. Patent Office Issues Sword Diagnostics Patent for Highly Sensitive Immunodetection Technology [0] Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development [0] Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing

... 1 C. Larry Pope, President and Chief Executive ... ), sent the following update to all employees on ... joint venture operation in Veracruz:To Our Employees:The media continues ... minute-to-minute basis, and while we would like to accommodate ...

... Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: ... quarterly royalty payment of approximately $1.5 million from ... for the treatment of Alzheimer,s disease. Under an ... payments on certain sales of Memantine by Merz ...

Other Medicine Technology:Smithfield Sends Update to Employees on Testing Process at Veracruz Joint Venture 2

Smithfield Sends Update to Employees on Testing Process at Veracruz Joint Venture Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine

CVC 223 is an assayed quality control material used for confirming the calibration and linearity of CO-Oximeter instrumentation....

... assayed quality control material used for monitoring the ... It is for specific use on Bayer analyzers ... 288, and 270) and the AVOX Systems CO-Oximeters ... used on the IRMA TRUpoint®. CC 527 is ...

... QC 623 is an assayed quality control material ... available in four (4) levels for monitoring analyzer ... It may be used on multiple test analyzers ... the Radiometer 600). QC623 is also for use ...

Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens....

Medicine Products:

CVC 223 CO-Oximeter Calibration Verification Controls CC 527 Blood Gas, Electrolyte, CO-Oximeter (Bayer® and AVOX Systems®) Control QC 623 Blood Gas, Electrolyte Control Equinox Cosmetic Enhancement Contact Lens

Merck Pays More Than $400 Million to Settle Federal, State Medicaid Fraud Investigation Sparked by Qui Tam Whistleblower Case Detailing Marketing Schemes for Vioxx(R), Zocor(R), Several O...(in a nationwide investigation by federal...),Health